Zheng W - Search Results

1

The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.

Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, Qian S, Xu W. Chen L, et al. Among authors: zheng w. Leuk Lymphoma. 2007 Sep;48(9):1785-92. doi: 10.1080/10428190701534416. Leuk Lymphoma. 2007. PMID: 17786715

2

[Multiple myeloma cell line U266 apoptosis induced by velcade].

Chen LJ, Li JY, Qian SX, Zhu GR, Zheng WJ. Chen LJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):696-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16928302 Chinese.

3

[Application of a four antibody (cMPO/cCD79aalpha/cCD3/CD45) combination to the diagnosis of acute leukemia expressing cross-lineage antigens].

Wu YJ, Li JY, Zhu MQ, Song JH, Zheng WJ. Wu YJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2006 Jul;27(7):449-51. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 17147246 Chinese.

4

[Detection of IgVH mutation status in patients with chronic lymphocytic leukemia by multiplex PCR].

Zheng WJ, Chen LJ, Wu YJ, Li L, Xu W, Li JY. Zheng WJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1101-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 17204172 Chinese.

5

Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.

Chen L, Zhang Y, Zheng W, Wu Y, Qiao C, Fan L, Xu W, Li J. Chen L, et al. Among authors: zheng w. Leuk Res. 2008 Oct;32(10):1491-8. doi: 10.1016/j.leukres.2008.02.005. Epub 2008 Mar 21. Leuk Res. 2008. PMID: 18359082

6

[Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].

Chen LJ, Zheng WJ, Wu YJ, Li L, Qian SX, Xu W, Li JY. Chen LJ, et al. Among authors: zheng wj. Zhonghua Xue Ye Xue Za Zhi. 2007 Nov;28(11):737-40. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18457263 Chinese.

7

[IgVH mutation status in patients with chronic lymphocytic leukemia].

Zhang YP, Chen LJ, Zheng WJ, Wu YJ, Qiu HX, Qian SX, Xu W, Li JY. Zhang YP, et al. Among authors: zheng wj. Zhonghua Xue Ye Xue Za Zhi. 2008 Mar;29(3):164-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18788614 Chinese.

8

BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.

Zhou C, Wu YL, Chen G, Liu X, Zhu Y, Lu S, Feng J, He J, Han B, Wang J, Jiang G, Hu C, Zhang H, Cheng G, Song X, Lu Y, Pan H, Zheng W, Yin AY. Zhou C, et al. Among authors: zheng w. J Clin Oncol. 2015 Jul 1;33(19):2197-204. doi: 10.1200/JCO.2014.59.4424. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014294 Clinical Trial.

9

Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial.

Zhou C, Huang D, Fan Y, Yu X, Liu Y, Shu Y, Ma Z, Wang Z, Cheng Y, Wang J, Hu S, Liu Z, Poddubskaya E, Disel U, Akopov A, Dvorkin M, Zheng W, Ma Y, Wang Y, Li S, Yu C, Rivalland G. Zhou C, et al. Among authors: zheng w. J Thorac Oncol. 2023 Jan;18(1):93-105. doi: 10.1016/j.jtho.2022.09.217. Epub 2022 Sep 29. J Thorac Oncol. 2023. PMID: 36184068 Free article. Clinical Trial.

10

Association among B lymphocyte subset and rheumatoid arthritis in a Chinese population.

You H, Cheng M, Ma C, Zheng W, Jiang Y, Chen D, Tang Y. You H, et al. Among authors: zheng w. J Orthop Surg Res. 2021 Dec 20;16(1):732. doi: 10.1186/s13018-021-02883-8. J Orthop Surg Res. 2021. PMID: 34930367 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,036 results

Search Page

Filters